Cerity Partners Portfolio holdings
AUM
$56.1B
1-Year Return
16.67%
This Quarter Return
+3.02%
1 Year Return
+16.67%
3 Year Return
+60.49%
5 Year Return
+100.94%
10 Year Return
–
AUM
$36.9B
AUM Growth
-$1.01B
(-2.7%)
Cap. Flow
-$1.82B
Cap. Flow
% of AUM
-4.94%
Top 10 Holdings %
Top 10 Hldgs %
25.86%
Holding
2,447
New
163
Increased
602
Reduced
1,348
Closed
228
Top Buys
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
$159M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
$101M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$89.1M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
$81.4M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$72.4M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$968M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
$113M |
| 3 |
Microsoft
MSFT
|
$89.5M |
| 4 |
Apple
AAPL
|
$78.4M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
$66.8M |
Sector Composition
| 1 | Technology | 16.34% |
| 2 | Financials | 7.53% |
| 3 | Healthcare | 7.45% |
| 4 | Consumer Staples | 5.64% |
| 5 | Consumer Discretionary | 4.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
3D Systems Corporation
DDD
$272M
| $85.4K | ﹤0.01% |
27,823
-37,595
| -57% | -$115K |
|
2127
Cemex
CX
$13.6B
| $84.9K | ﹤0.01% |
13,281
-7,873
| -37% | -$50.3K |
|
2128
Altice USA
ATUS
$1.05B
| $84K | ﹤0.01% |
41,163
-60,935
| -60% | -$124K |
|
2129
Organogenesis Holdings
ORGO
$634M
| $83.9K | ﹤0.01% |
+29,954
| New | +$83.9K |
|
|
BLUE
2130
DELISTED
bluebird bio
BLUE
| $81.2K | ﹤0.01% |
4,124
+642
| +18% | +$12.6K |
|
2131
Algonquin Power & Utilities
AQN
$4.35B
| $80.8K | ﹤0.01% |
13,787
+154
| +1% | +$902 |
|
2132
Companhia Siderúrgica Nacional
SID
$1.99B
| $80.5K | ﹤0.01% |
34,980
-5,650
| -14% | -$13K |
|
2133
Precigen
PGEN
$1.3B
| $80.2K | ﹤0.01% |
50,770
+5
| +0% | +$8 |
|
|
PHX
2134
DELISTED
PHX Minerals
PHX
| $80.1K | ﹤0.01% |
24,573
-8,942
| -27% | -$29.2K |
|
2135
Lucid Motors
LCID
$5.66B
| $79.4K | ﹤0.01% |
3,042
-1,064
| -26% | -$27.8K |
|
2136
ThredUp
TDUP
$1.43B
| $79.3K | ﹤0.01% |
46,640
+13
| +0% | +$22 |
|
2137
JetBlue
JBLU
$1.85B
| $79.1K | ﹤0.01% |
12,991
-16,738
| -56% | -$102K |
|
2138
SuRo Capital
SSSS
$207M
| $76.2K | ﹤0.01% |
+19,000
| New | +$76.2K |
|
2139
Under Armour
UAA
$2.2B
| $74.5K | ﹤0.01% |
11,174
+551
| +5% | +$3.68K |
|
2140
Kosmos Energy
KOS
$784M
| $74.5K | ﹤0.01% |
13,442
-1,772
| -12% | -$9.82K |
|
2141
UWM Holdings
UWMC
$1.38B
| $72.9K | ﹤0.01% |
+10,523
| New | +$72.9K |
|
2142
Pacific Biosciences
PACB
$381M
| $72.7K | ﹤0.01% |
53,043
+21,808
| +70% | +$29.9K |
|
|
CRON
2143
Cronos Group
CRON
$957M
| $72.3K | ﹤0.01% |
31,017
| – | – |
|
2144
BioCryst Pharmaceuticals
BCRX
$1.74B
| $71.9K | ﹤0.01% |
11,634
-738
| -6% | -$4.56K |
|
2145
QuantumScape
QS
$4.44B
| $71.3K | ﹤0.01% |
14,491
+154
| +1% | +$758 |
|
2146
Nordic American Tanker
NAT
$692M
| $67.1K | ﹤0.01% |
16,868
-1,741
| -9% | -$6.93K |
|
2147
Cytek Biosciences
CTKB
$511M
| $65.9K | ﹤0.01% |
+11,815
| New | +$65.9K |
|
|
AKTX
2148
Akari Therapeutics
AKTX
$26.7M
| $63.8K | ﹤0.01% |
23,643
| – | – |
|
2149
ATAI Life Sciences
ATAI
$980M
| $63.8K | ﹤0.01% |
47,965
-3,557
| -7% | -$4.73K |
|
2150
Amylyx Pharmaceuticals
AMLX
$910M
| $63.4K | ﹤0.01% |
+33,365
| New | +$63.4K |
|